Contineum Therapeutics, Inc Class A Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -83 | -85 | -81 | -79 |
EBITDA | -16,904 | -17,030 | -14,851 | -15,961 |
EBIT | -16,987 | -17,115 | -14,932 | -16,040 |
Net Income | -14,456 | -15,156 | -12,792 | -16,040 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,578 | -13,084 | -12,295 | -15,705 |
Cash | 20,158 | 75,603 | 42,633 | 20,784 |
Basic Shares | 37,339 | 30,863 | 28,115 | 25,895 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $50,000 | $0 |
Gross Profit | -323 | -258 | 50,000 | -329 |
EBITDA | -67,736 | -42,000 | 23,573 | -23,536 |
EBIT | -68,059 | -42,258 | 23,378 | -23,865 |
Net Income | -59,978 | -42,258 | 22,720 | -24,253 |
Net Change In Cash | 0 | 0 | 50,000 | 0 |
Free Cash Flow | -55,543 | -33,359 | 18,935 | -20,239 |
Cash | 75,603 | 21,943 | 15,526 | 5,569 |
Basic Shares | 27,700 | 25,854 | 25,130 | 25,130 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.39 |
2025-12-31 | -$0.49 |
2025-09-30 | -$0.45 |
2025-06-30 | -$0.62 |